{"product_id":"diabetes-status","title":"Diabetes Status","description":"\u003cp\u003eDiabetes Status Comprehensive diabetes assessment requires evaluation across multiple metabolic markers. This panel measures fasting glucose to establish current blood sugar levels, HbA1C to track average glycaemic control, insulin levels to assess pancreatic function and insulin resistance, and C-Peptide to evaluate endogenous insulin production. Together, these biomarkers distinguish between type 1 and type 2 diabetes, identify insulin resistance patterns, and reveal pancreatic beta-cell capacity. This integrated approach enables precise diagnosis, accurate risk stratification, and targeted intervention planning. Whether screening for undiagnosed diabetes or optimising management in established cases, these four measurements provide the clinical clarity needed to guide personalised treatment protocols and prevent progression to serious complications.\u003c\/p\u003e\n\u003ch6\u003e\u003cem\u003e*sample requirements: x3 Blood Sample\u003c\/em\u003e\u003c\/h6\u003e","brand":"Chxhealth","offers":[{"title":"UK Partnered Clinic","offer_id":55962025525574,"sku":null,"price":135.0,"currency_code":"GBP","in_stock":true},{"title":"Chxhealth Clinic (County Durham)","offer_id":55962025558342,"sku":null,"price":135.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0982\/8961\/5174\/files\/1_461d8629-d838-4615-8ff3-61152baf662a.png?v=1779892545","url":"https:\/\/www.chxhealth.co.uk\/products\/diabetes-status","provider":"Chxhealth","version":"1.0","type":"link"}